Sophia Drinis, MD | |
85 Herrick St, Beverly, MA 01915-1790 | |
(978) 816-3700 | |
Not Available |
Full Name | Sophia Drinis |
---|---|
Gender | Female |
Speciality | Urology |
Experience | 33 Years |
Location | 85 Herrick St, Beverly, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932175924 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Northeast Hospital Corporation | Beverly, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northeast Medical Practice Inc | 2365405024 | 188 |
News Archive
Grand Challenges Canada, funded by the Government of Canada, and the "Saving Brains" partners today announced investments in nine creative ways to protect and nurture the cognitive development of children in developing countries.
The Neuroendocrine Tumor Research Foundation today announced its largest research commitment ever - $4 million in collaborative grants - most from its new Accelerator Grants program to study neuroendocrine tumors, a widely misunderstood, commonly misdiagnosed cancer type, without adequately identified genomic drivers.
EXACT Sciences Corporation today commented on the addition of non-invasive stool-based DNA (sDNA) testing to the state colorectal cancer screening mandates of New Jersey and Maryland, as well as the decision by CIGNA, one of the nation's largest insurers, to include sDNA screening among its covered benefits nationally.
As previously announced, RaySearch Laboratories AB has been contacted by a US company named Prowess, which claims that RaySearch has infringed on a US patent in respect of which Prowess has a license.
› Verified 3 days ago
Entity Name | Lahey Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
Grand Challenges Canada, funded by the Government of Canada, and the "Saving Brains" partners today announced investments in nine creative ways to protect and nurture the cognitive development of children in developing countries.
The Neuroendocrine Tumor Research Foundation today announced its largest research commitment ever - $4 million in collaborative grants - most from its new Accelerator Grants program to study neuroendocrine tumors, a widely misunderstood, commonly misdiagnosed cancer type, without adequately identified genomic drivers.
EXACT Sciences Corporation today commented on the addition of non-invasive stool-based DNA (sDNA) testing to the state colorectal cancer screening mandates of New Jersey and Maryland, as well as the decision by CIGNA, one of the nation's largest insurers, to include sDNA screening among its covered benefits nationally.
As previously announced, RaySearch Laboratories AB has been contacted by a US company named Prowess, which claims that RaySearch has infringed on a US patent in respect of which Prowess has a license.
› Verified 3 days ago
Entity Name | Lahey Clinic Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063447316 PECOS PAC ID: 2264336528 Enrollment ID: O20040629001269 |
News Archive
Grand Challenges Canada, funded by the Government of Canada, and the "Saving Brains" partners today announced investments in nine creative ways to protect and nurture the cognitive development of children in developing countries.
The Neuroendocrine Tumor Research Foundation today announced its largest research commitment ever - $4 million in collaborative grants - most from its new Accelerator Grants program to study neuroendocrine tumors, a widely misunderstood, commonly misdiagnosed cancer type, without adequately identified genomic drivers.
EXACT Sciences Corporation today commented on the addition of non-invasive stool-based DNA (sDNA) testing to the state colorectal cancer screening mandates of New Jersey and Maryland, as well as the decision by CIGNA, one of the nation's largest insurers, to include sDNA screening among its covered benefits nationally.
As previously announced, RaySearch Laboratories AB has been contacted by a US company named Prowess, which claims that RaySearch has infringed on a US patent in respect of which Prowess has a license.
› Verified 3 days ago
Entity Name | Northeast Medical Practice Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235147760 PECOS PAC ID: 2365405024 Enrollment ID: O20050111000265 |
News Archive
Grand Challenges Canada, funded by the Government of Canada, and the "Saving Brains" partners today announced investments in nine creative ways to protect and nurture the cognitive development of children in developing countries.
The Neuroendocrine Tumor Research Foundation today announced its largest research commitment ever - $4 million in collaborative grants - most from its new Accelerator Grants program to study neuroendocrine tumors, a widely misunderstood, commonly misdiagnosed cancer type, without adequately identified genomic drivers.
EXACT Sciences Corporation today commented on the addition of non-invasive stool-based DNA (sDNA) testing to the state colorectal cancer screening mandates of New Jersey and Maryland, as well as the decision by CIGNA, one of the nation's largest insurers, to include sDNA screening among its covered benefits nationally.
As previously announced, RaySearch Laboratories AB has been contacted by a US company named Prowess, which claims that RaySearch has infringed on a US patent in respect of which Prowess has a license.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Sophia Drinis, MD Provider Enrollment 41 Mall Road, Burlington, MA 01805-0001 Ph: () - | Sophia Drinis, MD 85 Herrick St, Beverly, MA 01915-1790 Ph: (978) 816-3700 |
News Archive
Grand Challenges Canada, funded by the Government of Canada, and the "Saving Brains" partners today announced investments in nine creative ways to protect and nurture the cognitive development of children in developing countries.
The Neuroendocrine Tumor Research Foundation today announced its largest research commitment ever - $4 million in collaborative grants - most from its new Accelerator Grants program to study neuroendocrine tumors, a widely misunderstood, commonly misdiagnosed cancer type, without adequately identified genomic drivers.
EXACT Sciences Corporation today commented on the addition of non-invasive stool-based DNA (sDNA) testing to the state colorectal cancer screening mandates of New Jersey and Maryland, as well as the decision by CIGNA, one of the nation's largest insurers, to include sDNA screening among its covered benefits nationally.
As previously announced, RaySearch Laboratories AB has been contacted by a US company named Prowess, which claims that RaySearch has infringed on a US patent in respect of which Prowess has a license.
› Verified 3 days ago
Emilia Phillips, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr, Suite 304t, Beverly, MA 01915 Phone: 978-998-3154 Fax: 978-998-3156 | |
Yanina Barbalat, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 75 Herrick St Ste 219, Lahey Institue Of Urology, Beverly, MA 01915 Phone: 978-927-0714 | |
Dr. John S Ledbetter, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 75 Herrick St, Ste 219, Beverly, MA 01915 Phone: 978-927-0714 Fax: 978-927-9135 | |
Dr. Michael J Zachareas, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 900 Cummings Ctr, Suite 117t, Beverly, MA 01915 Phone: 978-232-9400 Fax: 978-232-9405 | |
Daniel Seth Blander, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 75 Herrick St, Suite 219, Beverly, MA 01915 Phone: 978-927-0714 Fax: 978-927-9135 | |
Dr. Marc Damian Manganiello, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 75 Herrick St Ste 219, Beverly, MA 01915 Phone: 978-927-0714 Fax: 978-927-9135 |